UNSPSC 51295300: Antidepressant spiro compounds and thiophenes and triazines

This classification denotes Antidepressant drugs made from or based in part on spiro compounds, thiophenes, or triazines

UNSPSC 51295300 Antidepressant spiro compounds and thiophenes and triazines is a Class code that does not align with the recent state and local opportunities posted under it. The three most recent solicitations tagged to this code cover naloxone and drug deactivation systems (Seminole County, Florida), direct-to-manufacturer prescription programs (Texas Health and Human Services Commission), and generic multi-source pharmaceuticals and OTC products through cooperative purchasing (Minnesota Multistate Cooperative Purchasing Alliance). None of these solicitations involve antidepressant compounds or specialized psychopharmaceutical products. The mismatch suggests either miscoding by issuing bodies or a taxonomic misalignment between the UNSPSC category name and the actual procurement activity being tagged under it.

The recent opportunities do reflect broader state and local demand for pharmaceutical sourcing, supply chain management, and health-system procurement. Seminole County's IFB (due July 26, 2023, though posted June 30, 2026) sought 1,900 units of naloxone and 800 drug deactivation systems annually with quarterly deliveries to a county health building. The Texas HHS Commission's April 2026 RFI explored direct-to-manufacturer prescription fulfillment models outside traditional PBM and GPO channels. MMCAP's March 2026 RFP established multi-state contracts for generic pharmaceuticals and OTC products distributed through three authorized wholesalers (AmerisourceBergen, Cardinal Health, Morris & Dickson), with pricing weighted 75 percent of the evaluation and contract terms through June 30, 2028. Given the code's stated focus on antidepressant compounds and the lack of matching recent activity, this code warrants close scrutiny before pursuing opportunities listed under it—confirm issuing-body coding practice and clarify scope alignment with your prospect before investing pre-bid resources.